Piriformis Syndrome Market – Highlights
Piriformis Syndrome is a rare neuromuscular condition in which the piriformis muscle, located in the buttock region, spasms and causes hip and buttock pain.
The conservative treatment for piriformis syndrome includes activity modification, the use of anti-inflammatory drugs, physical therapy, an injection of local anesthetics or corticosteroids, and botulin neurotoxin injections, among others.
GET FREE SAMPLE REPORT @ https://www.marketresearchfuture.com/sample_request/6249
Major factors such as the growing occurrence of piriformis syndrome, increasing screening for neuromuscular conditions, growing success of drug treatment for the syndrome, and the growing geriatric population are expected to drive the growth of the global piriformis syndrome market.
Additionally, according to the data published by the National Center for Biotechnology Information (NCBI), in 2015, the occurrence rate of piriformis syndrome was 6% in patients with sciatica symptoms.
Piriformis Syndrome Market – Key Players
- Bayer AG
- Novartis AG
- Endo Pharmaceuticals
- Teva Pharmaceuticals
- Omron Healthcare
- Sanofi S.A.
- DePuy Synthes Companies
- Miracle Stretch, LLC
- Flex Pharma, Inc.
- Nidd valley medical
- SEIRIN Corporation
Piriformis Syndrome Market – Regional Analysis
The global piriformis syndrome market consists of four regions, namely, the Americas, Europe, Asia-Pacific, and the Middle East and Africa.
The North American region holds the major share of the global piriformis syndrome market, owing to the existing well-established healthcare system, increasing secondary lifestyle, and increasing geriatric population.
Europe is anticipated to hold the second largest position in the global piriformis market owing to the growing government support for research and development activities.
Additionally, Asia-Pacific the piriformis market in Asia-Pacific consists of countries, namely, China, Japan, the Republic of Korea, India, Australia, and the rest of Asia-Pacific.
Piriformis Syndrome Market – Segmentation
The global piriformis syndrome market is segmented on the basis of cause, diagnostic test, treatment, distribution channel, and end-user. On the basis of cause, the market is classified as trauma, spasms, overuse injury, and others.
The piriformis syndrome market on the basis of diagnostic tests is segmented as Magnetic Resonance Imaging (MRI), X-ray, Computed Tomography (CT), neurophysiologic testing, Electromyography (EMG), Beatty Test, FAIR (Flexion, adduction, and Internal Rotation) test, and others.
On the basis of treatment, the market is segmented into medication, physical therapy, acupuncture, prolotherapy, Osteopathic Manipulative Treatment (OMT), surgery, and others. Medication is further segmented into NSAIDs, piriformis muscle injection, and others.
The global piriformis syndrome market, by distribution channel, is segmented into E-commerce, retail pharmacies, and others. On the basis of end-user, the global piriformis syndrome market is segmented as hospitals and clinics, diagnostic centers, and others.
BROWSE COMPLETE 100 PAGES PREMIUM RESEARCH REPORT ENABLED WITH RESPECTIVE TABLES AND FIGURES @ https://www.marketresearchfuture.com/reports/piriformis-syndrome-market-6249
Major Points form Table of Content of Global Piriformis Syndrome Market
Chapter 1. Report Prologue
Chapter 2. Market Introduction
Chapter 3. Research Methodology
Chapter 4. Market Dynamics
Chapter 5. Market Factor Analysis
Chapter 6. Global Piriformis Syndrome Market, By Type
Chapter 7. Global Piriformis Syndrome Market, By Treatment
Chapter 8 Global Piriformis Syndrome Market, By End User
Chapter 9. Global Piriformis Syndrome Market, By Region
Chapter 10 Company Landscape
Chapter 11 Company Profiles
Chapter 12 MRFR Conclusion
Chapter 13 Appendix
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Phone: +1 646 845 9312